Please ensure Javascript is enabled for purposes of website accessibility

Why Tilray Is Rallying Today

By Zhiyuan Sun – Aug 5, 2021 at 2:17PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors are excited about the Canadian marijuana company's international expansion potential.

What happened?

Shares of pot grower Tilray (TLRY 1.92%) are up 4.1% to $14.54 apiece as of 10:30 a.m. EDT. On Aug. 4, Tilray's CEO Irwin Simons gave an exclusive interview to cannabis business news outlet New Cannabis Ventures. Simons reiterated the strategy outlined in the company's recent earnings call: greater integration in the Canadian cannabis industry, continued momentum in Europe, and synergizing with the merging U.S. marijuana market. 

A person rolling a marijuana cigarette at home.

Image source: Getty Images.

So what

Tilray is on track for some spectacular growth. It has a substantial presence in the U.S. via its craft beer subsidiary SweetWater Brewing and hemp CBD subsidiary Manitoba Harvest. The company sees them growing to $200 million in annual sales in the near future. 

What's more, Tilray now holds a substantial market share in the German medical marijuana industry. Its subsidiary CC Pharma distributes pot across over 13,000 pharmacies in the country. 

Now what

The company has an ambitious goal of achieving 4 billion Canadian dollars in sales by 2024. That is a substantial gain from its CA$513.1 million in annual revenue today. But even if its expansion efforts fail, Tilray has a lot to fall back on. It holds a 16% market share in the Canadian marijuana sector, essentially tied with other industry leaders like Hexo (HEXO -1.19%) and Canopy Growth (CGC 0.59%). Consumers are especially fond of Tilray's vapes. From province to province, sectors are increasing by 125% to 220% year over year. For these reasons, it is definitely a solid marijuana stock to watch. 

Zhiyuan Sun has no position in any of the stocks mentioned. The Motley Fool recommends HEXO Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Canopy Growth Corp. Stock Quote
Canopy Growth Corp.
CGC
$3.42 (0.59%) $0.02
HEXO Corp. Stock Quote
HEXO Corp.
HEXO
$0.17 (-1.19%) $0.00
Tilray, Inc. Stock Quote
Tilray, Inc.
TLRY
$3.72 (1.92%) $0.07

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
351%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.